Susceptibility of 186 Nocardia Sp. Isolates to 20 Antimicrobial Agents

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2011 Mar 16

PMID 21402847

Citations 57

Authors

Julian Larruskain

Pedro Idigoras

Jose M Marimon

Emilio Perez-Trallero

Affiliations

Soon will be listed here.

Abstract

This study determined the antimicrobial susceptibilities of 186 clinical isolates of Nocardia spp. isolated in Gipuzkoa, northern Spain, between 1998 and 2009. Most isolates were recovered from respiratory samples, Nocardia nova, N. farcinica, N. cyriacigeorgica, N. abscessus, and N. carnea being the species most frequently isolated. Linezolid and amikacin were the only two antimicrobials to which all isolates were susceptible. The majority of N. flavorosea, N. carnea, and N. farcinica isolates were trimethoprim-sulfamethoxazole resistant.

Citing Articles

Liver cirrhosis complicated with pulmonary Nocardia infection: A case report and literature review.

Xiao Y, Wang H, Tian T, Zheng J, Liu M, Wang Q Medicine (Baltimore). 2024; 103(49):e40054.

PMID: 39654192 PMC: 11630956. DOI: 10.1097/MD.0000000000040054.

Nocardia farcinica pneumonia complicated by pneumocystis jiroveci infection in children with Neuromyelitis Optica Spectrum Disorders: a case report and literature review.

Liu L, Huang Y, Shu S, Zhou H, Fang F, Liu X Ital J Pediatr. 2024; 50(1):255.

PMID: 39617880 PMC: 11610104. DOI: 10.1186/s13052-024-01827-2.

Case report: Metagenomic next-generation sequencing for the diagnosis of rare infection in a patient with immune thrombocytopenia.

Liang X, Liu X, Huang Z, Qiu F, Jiang Y, Li C Front Med (Lausanne). 2024; 11:1425655.

PMID: 39568747 PMC: 11576201. DOI: 10.3389/fmed.2024.1425655.

Secreted protein NFA47630 from Nocardia farcinica IFM10152 induces immunoprotective effects in mice.

Han L, Ji X, Fan S, Shen J, Liang B, Li Z Trop Dis Travel Med Vaccines. 2024; 10(1):21.

PMID: 39402651 PMC: 11476605. DOI: 10.1186/s40794-024-00229-w.

Application of MALDI-TOF mass spectrometry for identification of Nocardia species.

Liu Y, Wu S, Deng J, Zhuang K, Tang Y, Wu N BMC Microbiol. 2024; 24(1):358.

PMID: 39304812 PMC: 11414273. DOI: 10.1186/s12866-024-03483-2.

References

Wallace Jr R, Brown B, Tsukamura M, Brown J, Onyi G . Clinical and laboratory features of Nocardia nova. J Clin Microbiol. 1991; 29(11):2407-11. PMC: 270347. DOI: 10.1128/jcm.29.11.2407-2411.1991. View

Torres O, Domingo P, Pericas R, Boiron P, Montiel J, Vazquez G . Infection caused by Nocardia farcinica: case report and review. Eur J Clin Microbiol Infect Dis. 2000; 19(3):205-12. DOI: 10.1007/s100960050460. View

Brown-Elliott B, Brown J, Conville P, Wallace Jr R . Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006; 19(2):259-82. PMC: 1471991. DOI: 10.1128/CMR.19.2.259-282.2006. View

Lai C, Tan C, Lin S, Liao C, Chou C, Hsu H . Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species. J Antimicrob Chemother. 2009; 64(1):73-8. DOI: 10.1093/jac/dkp144. View

Saubolle M, Sussland D . Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol. 2003; 41(10):4497-501. PMC: 254378. DOI: 10.1128/JCM.41.10.4497-4501.2003. View

Munoz J, Mirelis B, Aragon L, Gutierrez N, Sanchez F, Espanol M . Clinical and microbiological features of nocardiosis 1997-2003. J Med Microbiol. 2007; 56(Pt 4):545-550. DOI: 10.1099/jmm.0.46774-0. View

Martinez R, Reyes S, Menendez R . Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis. Curr Opin Pulm Med. 2008; 14(3):219-27. DOI: 10.1097/MCP.0b013e3282f85dd3. View

Cercenado E, Marin M, Sanchez-Martinez M, Cuevas O, Martinez-Alarcon J, Bouza E . In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother. 2006; 51(3):1102-4. PMC: 1803140. DOI: 10.1128/AAC.01102-06. View

Vera-Cabrera L, Campos-Rivera M, Escalante-Fuentes W, Pucci M, Ocampo-Candiani J, Welsh O . In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid. Antimicrob Agents Chemother. 2010; 54(5):2191-3. PMC: 2863655. DOI: 10.1128/AAC.01520-09. View

10.

Conville P, Brown J, Steigerwalt A, Brown-Elliott B, Witebsky F . Nocardia wallacei sp. nov. and Nocardia blacklockiae sp. nov., human pathogens and members of the "Nocardia transvalensis Complex". J Clin Microbiol. 2008; 46(4):1178-84. PMC: 2292930. DOI: 10.1128/JCM.02011-07. View

11.

Wallace Jr R, Steele L, Sumter G, Smith J . Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother. 1988; 32(12):1776-9. PMC: 176016. DOI: 10.1128/AAC.32.12.1776. View

12.

Steingrube V, Wilson R, Brown B, Jost Jr K, Blacklock Z, Gibson J . Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis. J Clin Microbiol. 1997; 35(4):817-22. PMC: 229682. DOI: 10.1128/jcm.35.4.817-822.1997. View

13.

Telenti A, Marchesi F, Balz M, Bally F, Bottger E, Bodmer T . Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993; 31(2):175-8. PMC: 262730. DOI: 10.1128/jcm.31.2.175-178.1993. View

14.

Glupczynski Y, Berhin C, Janssens M, Wauters G . Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect. 2006; 12(9):905-12. DOI: 10.1111/j.1469-0691.2006.01460.x. View